scispace - formally typeset
M

Martin Stangel

Researcher at Hannover Medical School

Publications -  337
Citations -  12014

Martin Stangel is an academic researcher from Hannover Medical School. The author has contributed to research in topics: Remyelination & Multiple sclerosis. The author has an hindex of 54, co-authored 324 publications receiving 9709 citations. Previous affiliations of Martin Stangel include Hochschule Hannover & Ruhr University Bochum.

Papers
More filters
Journal ArticleDOI

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

TL;DR: This study provides an overview of the clinical and paraclinical features of NMOSD in Caucasians and demonstrates a number of distinct disease characteristics in seropositive and seronegative patients.
Journal ArticleDOI

Transferrin receptor internalization sequence YXRF implicates a tight turn as the structural recognition motif for endocytosis

TL;DR: Two distinct internalization sequences favor a common structural chemistry and implicate an exposed tight turn as the recognition motif for high efficiency endocytosis.
Journal ArticleDOI

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, +623 more
- 01 Dec 2017 - 
TL;DR: A phase 3, randomised, double-blind, placebo-controlled, multicentre study in 76 hospitals and specialised clinics across North America, Latin America, Europe, and Asia to assess the efficacy and safety of eculizumab in patients with refractory myasthenia gravis.
Journal ArticleDOI

Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination

TL;DR: Data demonstrate for the first time in vivo that astrocytes provide the signal environment that forms the basis for the recruitment of microglia to clear myelin debris, a process required for subsequent repair mechanisms in demyelinating diseases such as multiple sclerosis.